Advertisement
Screener

ILLUMINA, INC. (ILMN) Proceeds from Sale of Available-for-sale Securities

2.1 / 5 stars · 51/120 Roast Me

ILLUMINA, INC. Proceeds from Sale of Available-for-sale Securities

ILLUMINA, INC. (ILMN) reported Proceeds from Sale of Available-for-sale Securities of $520.00 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-24.

Discontinued › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2018-10-24

  • ILLUMINA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2018-09-30 was $188.00M, a 7.43% increase year-over-year.
  • ILLUMINA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2018-07-01 was $44.00M, a 55.56% decline year-over-year.
  • ILLUMINA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2018-04-01 was $288.00M, a 620.00% increase year-over-year.
  • ILLUMINA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2017-12-31 was $8.00M, a 94.16% decline year-over-year.
  • ILLUMINA, INC. proceeds from sale of available-for-sale securities for fiscal 2017 was $322.00M, a 40.70% decline from fiscal 2017.
  • ILLUMINA, INC. proceeds from sale of available-for-sale securities for fiscal 2017 was $543.00M, a 6.70% decline from fiscal 2016.
  • ILLUMINA, INC. proceeds from sale of available-for-sale securities for fiscal 2016 was $582.00M, a 48.60% increase from fiscal 2014.
  • ILLUMINA, INC. proceeds from sale of available-for-sale securities for fiscal 2014 was $391.65M, a 25.20% decline from fiscal 2013.
Period endProceeds from Sale of Available-for-sale Securities 3 monthProceeds from Sale of Available-for-sale Securities 3 month as first filedProceeds from Sale of Available-for-sale Securities 6 monthProceeds from Sale of Available-for-sale Securities 6 month as first filedProceeds from Sale of Available-for-sale Securities 9 monthProceeds from Sale of Available-for-sale Securities 9 month as first filedProceeds from Sale of Available-for-sale Securities 12 monthProceeds from Sale of Available-for-sale Securities 12 month as first filed
2018-09-30$188.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-24
$232.00M
derived: sum of 2 quarters · filed 2018-10-24
$520.00M
10-Q · filed 2018-10-24
$528.00M
derived: sum of 4 quarters · filed 2018-10-24
2018-07-01$44.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31
$332.00M
10-Q · filed 2018-07-31
$340.00M
derived: sum of 3 quarters · filed 2018-07-31
$515.00M
derived: sum of 4 quarters · filed 2018-10-24
2018-04-01$288.00M
10-Q · filed 2018-04-25
$296.00M
derived: sum of 2 quarters · filed 2018-04-25
$471.00M
derived: sum of 3 quarters · filed 2018-10-24
$570.00M
derived: sum of 4 quarters · filed 2018-10-24
2017-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$183.00M
derived: sum of 2 quarters · filed 2018-10-24
$282.00M
derived: sum of 3 quarters · filed 2018-10-24
$322.00M
10-K · filed 2018-02-13
2017-10-01$175.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-24
$274.00M
derived: sum of 2 quarters · filed 2018-10-24
$314.00M
10-Q · filed 2018-10-24
$451.00M
derived: sum of 4 quarters · filed 2018-10-24
2017-07-02$99.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31
$139.00M
10-Q · filed 2018-07-31
$276.00M
derived: sum of 3 quarters · filed 2018-07-31
$347.00M
derived: sum of 4 quarters · filed 2018-07-31
2017-04-02$40.00M
10-Q · filed 2018-04-25
$177.00M
derived: sum of 2 quarters · filed 2018-04-25
$248.00M
derived: sum of 3 quarters · filed 2018-04-25
$544.00M
derived: sum of 4 quarters · filed 2018-04-25
2017-01-01$137.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$208.00M
derived: sum of 2 quarters · filed 2018-02-13
$504.00M
derived: sum of 3 quarters · filed 2018-02-13
$543.00M
10-K · filed 2018-02-13
$543.25M
10-K · filed 2017-02-14
2016-10-02$71.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25
$367.00M
derived: sum of 2 quarters · filed 2017-10-25
$406.00M
10-Q · filed 2017-10-25
$406.29M
10-Q · filed 2016-11-08
$652.65M
derived: sum of 4 quarters · filed 2018-02-13
2016-07-03$296.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$335.00M
10-Q · filed 2017-08-03
$335.30M
10-Q · filed 2016-08-02
$581.65M
derived: sum of 3 quarters · filed 2018-02-13
$653.55M
derived: sum of 4 quarters · filed 2018-02-13
2016-04-03$39.00M
10-Q · filed 2017-05-05
$39.01M
10-Q · filed 2016-05-09
$285.65M
derived: sum of 2 quarters · filed 2018-02-13
$357.55M
derived: sum of 3 quarters · filed 2018-02-13
$468.84M
derived: sum of 4 quarters · filed 2018-02-13
2016-01-03$246.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$318.55M
derived: sum of 2 quarters · filed 2018-02-13
$429.84M
derived: sum of 3 quarters · filed 2018-02-13
$582.00M
10-K · filed 2018-02-13
$582.53M
10-K · filed 2016-03-02
2015-09-27$71.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
$183.19M
derived: sum of 2 quarters · filed 2016-11-08
$335.35M
10-Q · filed 2016-11-08
$402.45M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-28$111.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02
$263.45M
10-Q · filed 2016-08-02
$330.55M
derived: sum of 3 quarters · filed 2017-02-14
$363.84M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-29$152.16M
10-Q · filed 2016-05-09
$219.26M
derived: sum of 2 quarters · filed 2017-02-14
$252.55M
derived: sum of 3 quarters · filed 2017-02-14
$454.78M
derived: sum of 4 quarters · filed 2017-02-14
2014-12-28$67.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$100.39M
derived: sum of 2 quarters · filed 2017-02-14
$302.63M
derived: sum of 3 quarters · filed 2017-02-14
$391.65M
10-K · filed 2017-02-14
2014-09-28$33.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
$235.52M
derived: sum of 2 quarters · filed 2015-11-02
$324.55M
10-Q · filed 2015-11-02
$335.67M
derived: sum of 4 quarters · filed 2016-03-02
2014-06-29$202.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31
$291.26M
10-Q · filed 2015-07-31
$302.38M
derived: sum of 3 quarters · filed 2016-03-02
$313.86M
derived: sum of 4 quarters · filed 2016-03-02
2014-03-30$89.03M
10-Q · filed 2015-05-01
$100.15M
derived: sum of 2 quarters · filed 2016-03-02
$111.63M
derived: sum of 3 quarters · filed 2016-03-02
$334.48M
derived: sum of 4 quarters · filed 2016-03-02
2013-12-29$11.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02
$22.60M
derived: sum of 2 quarters · filed 2016-03-02
$245.45M
derived: sum of 3 quarters · filed 2016-03-02
$523.63M
10-K · filed 2016-03-02
2013-09-29$11.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29
$234.34M
derived: sum of 2 quarters · filed 2014-10-29
$512.52M
10-Q · filed 2014-10-29
$622.70M
10-Q · filed 2013-11-06
$344.31M
derived: sum of 4 quarters · filed 2015-02-18
2013-06-30$222.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
$501.04M
10-Q · filed 2014-08-01
$604.03M
10-Q · filed 2013-07-29
$332.83M
derived: sum of 3 quarters · filed 2015-02-18
$639.77M
derived: sum of 4 quarters · filed 2015-02-18
2013-03-31$278.18M
10-Q · filed 2014-05-07
$322.95M
10-Q · filed 2013-05-01
$109.97M
derived: sum of 2 quarters · filed 2015-02-18
$416.92M
derived: sum of 3 quarters · filed 2015-02-18
$587.79M
derived: sum of 4 quarters · filed 2015-02-18
2012-12-30-$168.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18
$138.73M
derived: sum of 2 quarters · filed 2015-02-18
$309.61M
derived: sum of 3 quarters · filed 2015-02-18
$498.37M
10-K · filed 2015-02-18
$733.33M
10-K · filed 2013-02-15
2012-09-30$306.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
$477.81M
derived: sum of 2 quarters · filed 2013-11-06
$666.58M
10-Q · filed 2013-11-06
$519.65M
derived: sum of 4 quarters · filed 2014-02-18
2012-07-01$170.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29
$359.64M
10-Q · filed 2013-07-29
$212.71M
derived: sum of 3 quarters · filed 2014-02-18
$534.76M
derived: sum of 4 quarters · filed 2014-02-18
2012-04-01$188.77M
10-Q · filed 2013-05-01
$41.84M
derived: sum of 2 quarters · filed 2014-02-18
$363.89M
derived: sum of 3 quarters · filed 2014-02-18
$540.08M
derived: sum of 4 quarters · filed 2014-02-18
2012-01-01-$146.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18
$175.12M
derived: sum of 2 quarters · filed 2014-02-18
$351.31M
derived: sum of 3 quarters · filed 2014-02-18
$568.45M
10-K · filed 2014-02-18
$900.88M
10-K · filed 2012-02-24
2011-10-02$322.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29
$498.24M
derived: sum of 2 quarters · filed 2012-10-29
$715.38M
10-Q · filed 2012-10-29
2011-07-03$176.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30
$393.32M
10-Q · filed 2012-07-30
2011-04-03$217.13M
10-Q · filed 2012-05-03
2011-01-02$539.16M
10-K · filed 2013-02-15
2010-01-03$310.23M
10-K · filed 2012-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
WATERS CORP /DE/ (WAT)United States$42.297B224.28
AGILENT TECHNOLOGIES, INC. (A)United States$48.720B27.14
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
REVVITY, INC. (RVTY)United States$16.814B53.44
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53